Cutaneous Events Associated with Immunotherapy of Melanoma: A Review

Immunotherapy with checkpoint inhibitors significantly improves the outcome for stage III and IV melanoma. Cutaneous adverse events during treatment are often reported. We herein aim to review the principal pigmentation changes induced by immune check-point inhibitors: the appearance of vitiligo, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Burzi, Lorenza, Alessandrini, Aurora Maria, Quaglino, Pietro, Piraccini, Bianca Maria, Dika, Emi, Ribero, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308045/
https://www.ncbi.nlm.nih.gov/pubmed/34300213
http://dx.doi.org/10.3390/jcm10143047
_version_ 1783728187892563968
author Burzi, Lorenza
Alessandrini, Aurora Maria
Quaglino, Pietro
Piraccini, Bianca Maria
Dika, Emi
Ribero, Simone
author_facet Burzi, Lorenza
Alessandrini, Aurora Maria
Quaglino, Pietro
Piraccini, Bianca Maria
Dika, Emi
Ribero, Simone
author_sort Burzi, Lorenza
collection PubMed
description Immunotherapy with checkpoint inhibitors significantly improves the outcome for stage III and IV melanoma. Cutaneous adverse events during treatment are often reported. We herein aim to review the principal pigmentation changes induced by immune check-point inhibitors: the appearance of vitiligo, the Sutton phenomenon, melanosis and hair and nail toxicities.
format Online
Article
Text
id pubmed-8308045
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83080452021-07-25 Cutaneous Events Associated with Immunotherapy of Melanoma: A Review Burzi, Lorenza Alessandrini, Aurora Maria Quaglino, Pietro Piraccini, Bianca Maria Dika, Emi Ribero, Simone J Clin Med Review Immunotherapy with checkpoint inhibitors significantly improves the outcome for stage III and IV melanoma. Cutaneous adverse events during treatment are often reported. We herein aim to review the principal pigmentation changes induced by immune check-point inhibitors: the appearance of vitiligo, the Sutton phenomenon, melanosis and hair and nail toxicities. MDPI 2021-07-08 /pmc/articles/PMC8308045/ /pubmed/34300213 http://dx.doi.org/10.3390/jcm10143047 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Burzi, Lorenza
Alessandrini, Aurora Maria
Quaglino, Pietro
Piraccini, Bianca Maria
Dika, Emi
Ribero, Simone
Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
title Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
title_full Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
title_fullStr Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
title_full_unstemmed Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
title_short Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
title_sort cutaneous events associated with immunotherapy of melanoma: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308045/
https://www.ncbi.nlm.nih.gov/pubmed/34300213
http://dx.doi.org/10.3390/jcm10143047
work_keys_str_mv AT burzilorenza cutaneouseventsassociatedwithimmunotherapyofmelanomaareview
AT alessandriniauroramaria cutaneouseventsassociatedwithimmunotherapyofmelanomaareview
AT quaglinopietro cutaneouseventsassociatedwithimmunotherapyofmelanomaareview
AT piraccinibiancamaria cutaneouseventsassociatedwithimmunotherapyofmelanomaareview
AT dikaemi cutaneouseventsassociatedwithimmunotherapyofmelanomaareview
AT riberosimone cutaneouseventsassociatedwithimmunotherapyofmelanomaareview

Ejemplares similares